We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App





Thermo Fisher Showcases Transformative Diagnostic Solutions

By LabMedica International staff writers
Posted on 29 Jul 2025

Thermo Fisher Scientific Inc. More...

(Waltham, MA; USA) is showcasing its comprehensive diagnostics solutions to help effectively assess clinical risk and diagnose disease, advance precision medicine, and further clinical research. Thermo Fisher is offering dynamic activities throughout the week, including more than 20 short lectures on various topics designed to help elevate laboratory performance and capabilities.

Visitors to Thermo Fisher’s booth at ADLM 2025 can experience its solutions firsthand during personalized product demonstrations and learn how the company’s diagnostics solutions help transform patient care. Visitors can also request tailored product demonstrations or schedule time to discuss solutions to help address their lab's needs. At ADLM 2025, Thermo Fisher is presenting new technologies and testing solutions that could enhance scientific results, boost operational efficiency, and advance clinical capabilities. Thermo Fisher is showcasing Aesku’s portfolio of FDA-cleared IFA products, automated instruments, like the Helios HTC, and software.

Thermo Fisher is also highlighting EliA assays, which help provide unparalleled focus on automation and workflow efficiency to support earlier diagnosis and improve care for patients with autoimmune conditions. Enabling faster and more accurate diagnoses for patients with complex autoimmune conditions, the Helios IFA System, together with the EliA portfolio, run on Phadia Laboratory Systems, meets the evolving needs of laboratories and allows for more efficient workflows by providing the most comprehensive suite of automated diagnostic systems and methodologies available in the U.S. market.

Binding Site, part of Thermo Fisher, is also participating in ADLM 2025, where it is showcasing its Optilite analyzer for special protein analysis that features an extensive assay menu for comprehensive testing options. The compact Optilite system features fully automated dilutions plus unrestricted access for samples and reagents, enabling a streamlined workflow for the entire laboratory. The Optilite system utilizes proven turbidimetric technology, which is known to be fast, robust, and versatile, becoming the main technology for protein diagnostics worldwide. Combining the Optilite system’s ease of use with Binding Site’s high-quality latex-enhanced assays gives peace of mind and the freedom to allocate time and resources in the most efficient way. Visitors can also experience Binding Site’s future innovative solution, the EXENT System, a mass spectrometry solution for M-protein assessment.

Related Links:
Thermo Fisher Scientific Inc.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Manual Pipetting Aid
Pipette Controllers macro
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Acute lymphoblastic leukemia in children and young people requires careful relapse risk assessment as treatment expands beyond standard chemotherapy. (Image Credit: Shutterstock)

New Risk-Stratification Tool Predicts Relapse After Blinatumomab in Childhood ALL

Acute lymphoblastic leukemia in children and young people requires careful assessment of relapse risk, particularly as treatment approaches move beyond standard chemotherapy. Traditional relapse predictors... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Decentralized Laboratory Network Improves Detection of Viral Hemorrhagic Fevers in Guinea

Viral hemorrhagic fevers remain a major diagnostic challenge in West Africa because their early symptoms can resemble those of other febrile illnesses. The 2014–2016 Ebola epidemic underscored the need... Read more

Pathology

view channel
Image: The automated IHC assay helps identify mesothelioma and distinguish it from other malignancies, including NSCLC. (Image Credit: Shutterstock)

Roche Launches Automated Test to Support Mesothelioma Differential Diagnosis

Mesothelioma is a rare, deadly cancer that forms in the tissue lining many internal organs. Most patients are diagnosed late, with median overall survival reported at 12 to 18 months. Differential diagnosis... Read more

Technology

view channel
Image: Diatech Pharmacogenetics launches Labcycler, a compact PCR thermal cycler. (Photo courtesy of Diatech Pharmacogenetics)

Compact PCR Thermal Cycler Launches for Routine Molecular Laboratory Workflows

Molecular laboratories rely on nucleic acid analysis to detect molecular information accurately and reproducibly across a wide range of applications. Supporting these routine workflows, a newly launched... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.